- Home
- ATAI vs SAR Comparison
ATAI vs SAR Comparison
Compare ATAI & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- SAR
- Stock Information
- Founded
- ATAI 2018
- SAR 2007
- Country
- ATAI Germany
- SAR United States
- Employees
- ATAI N/A
- SAR N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- SAR Investment Managers
- Sector
- ATAI Health Care
- SAR Finance
- Exchange
- ATAI Nasdaq
- SAR Nasdaq
- Market Cap
- ATAI 444.7M
- SAR 402.9M
- IPO Year
- ATAI 2021
- SAR 2007
- Fundamental
- Price
- ATAI $4.57
- SAR $25.24
- Analyst Decision
- ATAI Strong Buy
- SAR Hold
- Analyst Count
- ATAI 3
- SAR 4
- Target Price
- ATAI $13.33
- SAR $24.75
- AVG Volume (30 Days)
- ATAI 6.3M
- SAR 112.5K
- Earning Date
- ATAI 08-14-2025
- SAR 10-07-2025
- Dividend Yield
- ATAI N/A
- SAR 11.88%
- EPS Growth
- ATAI N/A
- SAR 105.87
- EPS
- ATAI N/A
- SAR 2.47
- Revenue
- ATAI $2,309,000.00
- SAR $142,495,705.00
- Revenue This Year
- ATAI $423.05
- SAR N/A
- Revenue Next Year
- ATAI N/A
- SAR $1.97
- P/E Ratio
- ATAI N/A
- SAR $10.22
- Revenue Growth
- ATAI 510.85
- SAR N/A
- 52 Week Low
- ATAI $1.03
- SAR $21.10
- 52 Week High
- ATAI $4.74
- SAR $26.49
- Technical
- Relative Strength Index (RSI)
- ATAI 70.54
- SAR 52.36
- Support Level
- ATAI $3.60
- SAR $25.20
- Resistance Level
- ATAI $4.23
- SAR $25.59
- Average True Range (ATR)
- ATAI 0.33
- SAR 0.33
- MACD
- ATAI -0.01
- SAR 0.02
- Stochastic Oscillator
- ATAI 85.09
- SAR 70.23
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About SAR Saratoga Investment Corp New
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.